Half-year report · HY
6960.TEDINET S100X29Y
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥64.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥139.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥64.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥10.7bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥10.7bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥10.9bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥26.6bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥11.3bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥11.0bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥11.4bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.6bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥18.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.7bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥7.6bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥7.7bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥212.9bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥221.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥204.8bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥34.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥39.7bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥178.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥181.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥172.0bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥65.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥72.4bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥60.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥67.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥61.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥57.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥16.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥33.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥9.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥17.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥13.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥273.47 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥645.41 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥267.34 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 83.6% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Consumables And Other Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥18.9bn |
| Consumables And Other Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥18.9bn |
| Consumables And Other Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.7bn |
| Medical Treatment Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥31.3bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥31.3bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥5.8bn |
| Patient Monitoring Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.5bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.5bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥574m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥11.1bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥11.1bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥64.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥64.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥10.7bn |
| Consumables And Other Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥17.8bn |
| Consumables And Other Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥17.8bn |
| Consumables And Other Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| Medical Treatment Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥30.5bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥30.5bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥5.6bn |
| Patient Monitoring Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥4.1bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥4.1bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥658m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥11.9bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.9bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥64.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥64.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥10.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 532
| Item | Context | Value | Unit |
|---|---|---|---|
| Type of current period | FilingDateInstant | HY | |
| Current fiscal year end date | FilingDateInstant | 2026-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Comparative period end date | FilingDateInstant | 2024-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)センチュリー産業㈱ | |
| Address major shareholders | InterimInstant_No1MajorShareholdersMember | Original text (Japanese)東京都文京区本郷３-13-６ | |
| Name major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)福田 孝太郎 | |
| Address major shareholders | InterimInstant_No2MajorShareholdersMember | Original text (Japanese)東京都文京区 | |
| Name major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)日本生命保険（相） | |
| Address major shareholders | InterimInstant_No3MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１－６－６日本生命証券管理部内 | |
| Name major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)みずほ信託銀行㈱ 退職給付信託きらぼし銀行口 再信託受託者 ㈱日本カストディ銀行 | |
| Address major shareholders | InterimInstant_No4MajorShareholdersMember | Original text (Japanese)東京都中央区晴海１－８－12 | |
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)㈱三菱ＵＦＪ銀行 | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内１－４－５ | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)㈱みずほ銀行 | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)東京都千代田区大手町１－５－５ | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)㈱北陸銀行 | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)富山県富山市堤町通り１－２－26 | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)福田 百合子 | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東京都文京区 | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)フクダ電子従業員持株会 | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)東京都文京区本郷２－35－８ | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)公益財団法人福田記念医療技術振興財団 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)東京都文京区湯島２－31－20 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |